Availability and utilization of molecular testing for primary central nervous system tumors among US hospitals.

导出 OA

翻译打印收藏纠错

作者： Megan,Parker ^[1] ; Foad,Kazemi ^[1] ; Asha,Krishnakumar ^[2] ; Melanie A,Horowitz ^[1] ; Saket,Myneni ^[1] ; Abby,Liu ^[1] ; Karisa C,Schreck ^[3] ; Calixto-Hope G,Lucas ^[4] ; Debraj,Mukherjee ^[1]

作者单位： Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ^[1] School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. ^[2] Department of Neurology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA. ^[3] Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ^[4]

关键词 Central nervous system Molecular Sequencing Tumor

主题词人类(Humans);中枢神经系统肿瘤(Central Nervous System Neoplasms);美国(United States);医院(Hospitals)

DOI 10.1093/jnen/nlae035

PMID 38687613

发布时间 2024-06-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交